David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
3551
DELISTED
Apellis Pharmaceuticals
APLS
| $667K | ﹤0.01% |
12,898
-184,466
| -93% | -$9.78M |
|
3552
Phibro Animal Health
PAHC
$1.46B
| $666K | ﹤0.01% |
49,662
+3,345
| +7% | +$44.9K |
|
3553
Yeti Holdings
YETI
$3.07B
| $666K | ﹤0.01% |
16,118
-24,260
| -60% | -$911K |
|
3554
PUT
RXO
RXO
$3.66B
| $666K | ﹤0.01% |
+38,700
| New | +$686K |
|
3555
CALL
Skyworks Solutions
SWKS
$9.84B
| $665K | ﹤0.01% |
7,300
+1,100
| +18% | +$98.6K |
|
3556
CALL
Ally Financial
ALLY
$13B
| $665K | ﹤0.01% |
27,200
+6,400
| +31% | +$170K |
|
|
CNCE
3557
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $665K | ﹤0.01% |
+113,848
| New | +$599K |
|
3558
MBIA
MBI
$252M
| $662K | ﹤0.01% |
+51,523
| New | +$589K |
|
3559
Univest Financial
UVSP
$1.15B
| $661K | ﹤0.01% |
25,304
+2,602
| +11% | +$69.8K |
|
3560
Astec Industries
ASTE
$1.01B
| $661K | ﹤0.01% |
+16,246
| New | +$656K |
|
3561
Anterix
ATEX
$1.84B
| $659K | ﹤0.01% |
20,480
+811
| +4% | +$27.6K |
|
3562
CALL
Welltower
WELL
$174B
| $656K | ﹤0.01% |
10,000
| – | – |
|
|
PFTA
3563
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
| $653K | ﹤0.01% |
65,153
+104
| +0.2% | +$1.03K |
|
3564
CALL
Groupon
GRPN
$769M
| $652K | ﹤0.01% |
+76,000
| New | +$588K |
|
|
NKLA
3565
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $650K | ﹤0.01% |
+10,027
| New | +$838K |
|
3566
Ichor Holdings
ICHR
$2.15B
| $649K | ﹤0.01% |
+24,212
| New | +$646K |
|
|
LAZR
3567
CALL
DELISTED
Luminar Technologies
LAZR
| $648K | ﹤0.01% |
8,727
| – | – |
|
|
MORF
3568
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $647K | ﹤0.01% |
24,203
-21,453
| -47% | -$586K |
|
3569
PUT
Novavax
NVAX
$1.51B
| $643K | ﹤0.01% |
62,500
-20,000
| -24% | -$353K |
|
3570
N-able
NABL
$701M
| $642K | ﹤0.01% |
62,497
-16,108
| -20% | -$172K |
|
|
HEES
3571
DELISTED
H&E Equipment Services
HEES
| $642K | ﹤0.01% |
14,136
-70,156
| -83% | -$2.72M |
|
3572
State Street SPDR S&P Homebuilders ETF
XHB
$1.41B
| $639K | ﹤0.01% |
10,600
+1,900
| +22% | +$113K |
|
|
KNBE
3573
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $639K | ﹤0.01% |
25,775
-99,115
| -79% | -$2.41M |
|
|
CGAU
3574
Centerra Gold
CGAU
$4.65B
| $637K | ﹤0.01% |
+123,100
| New | +$610K |
|
3575
Sprinklr
CXM
$1.75B
| $637K | ﹤0.01% |
77,922
+48,334
| +163% | +$418K |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.